Specialized Expertise ChanTest’s focus on ion channel and GPCR safety testing positions it as a key partner for pharmaceutical companies seeking specialized nonclinical assays, creating opportunities to expand services in novel drug discovery where precise target validation is critical.

Trusted Industry Leader With a reputation as the most trusted provider in ion channel screening and a longstanding presence in the market since 1998, ChanTest presents a reliable partner for clients seeking high-quality, validated testing services to accelerate their regulatory approval processes.

Small but Agile Despite having a modest team size, the company’s extensive library of validated cell lines and comprehensive cardiac risk assessment services enable personalized, flexible partnerships that cater to the specific needs of biotech startups and emerging pharma firms.

Global Client Base Serving over 300 international pharma and biotech customers indicates strong potential to grow by targeting new geographic markets or expanding into adjacent areas such as personalized medicine and advanced cardiovascular safety testing.

Growth Potential With revenue in the range of one to ten million dollars, there are opportunities for strategic investments in expanding testing capacity, adopting new high-throughput technologies, or diversifying into related therapeutic areas to enhance market penetration.